for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Baxter International Inc

BAX.N

Latest Trade

87.20USD

Change

-0.83(-0.94%)

Volume

604,056

Today's Range

87.13

 - 

88.26

52 Week Range

61.06

 - 

89.93

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Baxter Launches Prismax In Canada To Maximize Treatment In ICU

Aug 12 (Reuters) - Baxter International Inc <BAX.N>::BAXTER LAUNCHES PRISMAX IN CANADA TO MAXIMIZE TREATMENT IN THE INTENSIVE CARE UNIT.BAXTER CANADA - ANNOUNCED HEALTH CANADA'S APPROVAL OF ITS PRISMAX SYSTEM AND INTEGRATED THERMAX BLOOD WARMER.BAXTER CANADA - EXPECTS TO FILE FOR REGULATORY APPROVAL OF PRISMAX IN ADDITIONAL COUNTRIES IN 2019 AND 2020.

Baxter Reports Second Quarter GAAP Earnings Per Share Of $0.66

July 25 (Reuters) - Baxter International Inc <BAX.N>::BAXTER REPORTS SECOND-QUARTER 2019 RESULTS.Q2 GAAP EARNINGS PER SHARE $0.66.Q2 EARNINGS PER SHARE ESTIMATE $0.81 -- REFINITIV IBES DATA.SEES Q3 2019 ADJUSTED EARNINGS PER SHARE $0.82 TO $0.84 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.34 TO $3.40 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES Q3 2019 GAAP EARNINGS PER SHARE $0.75 TO $0.78 FROM CONTINUING OPERATIONS.SEES FY 2019 GAAP EARNINGS PER SHARE $2.81 TO $2.89 FROM CONTINUING OPERATIONS.Q2 REVENUE $2.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.79 BILLION.BAXTER INTERNATIONAL - PLANS TO SCALE INVESTMENTS IN U.S. TO ALIGN WITH PROPOSED MODELS FROM CMS AND PATIENT AND MARKET DYNAMICS ACROSS ADOPTION CURVE.BAXTER INTERNATIONAL - INVESTMENTS ARE ANTICIPATED AT $500 MILLION IN POTENTIAL NEW U.S. FACILITIES & IN EXISTING SITES.BAXTER INTERNATIONAL - ANTICIPATES THE INVESTMENTS TO HELP ACCELERATE RENAL CARE GROWTH,CONTRIBUTE POSITIVELY TO CO'S PREVIOUS FINANCIAL COMMITMENTS.EXPECTS Q3 SALES GROWTH OF 3% TO 4% ON A REPORTED BASIS.BAXTER INTERNATIONAL - SEES FY SALES GROWTH OF 1% TO 2% ON A REPORTED BASIS, AND APPROXIMATELY 4% ON BOTH A CONSTANT CURRENCY AND OPERATIONAL BASIS.EXPECTS Q3 SALES TO GROW APPROXIMATELY 5% ON BOTH A CONSTANT CURRENCY AND OPERATIONAL BASIS.Q3 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $2.84 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $3.33, REVENUE VIEW $11.21 BILLION -- REFINITIV IBES DATA.

Baxter Announces U.S. FDA Approval Of Myxredlin, Ready-To-Use Insulin For IV Infusion

July 22 (Reuters) - Baxter International Inc <BAX.N>::BAXTER ANNOUNCES U.S. FDA APPROVAL OF MYXREDLIN, THE FIRST AND ONLY READY-TO-USE INSULIN FOR IV INFUSION.BAXTER INTERNATIONAL INC - MYXREDLIN IS EXPECTED TO BE AVAILABLE FROM BAXTER IN UNITED STATES BEFORE END OF YEAR.BAXTER INTERNATIONAL INC- OFFERS EXTENDED SHELF LIFE OF 30 DAYS AT ROOM TEMPERATURE OR 24 MONTHS REFRIGERATED.BAXTER INTERNATIONAL - MYXREDLIN OFFERS EXTENDED SHELF LIFE OF 30 DAYS AT ROOM TEMPERATURE OR 24 MONTHS REFRIGERATED (ADDS DROPPED WORD).

Baxter International Declares Qtrly Cash Dividend Of $0.22 Per Share

July 16 (Reuters) - Baxter International Inc <BAX.N>::SETS QUARTERLY CASH DIVIDEND OF $0.22PER SHARE.

Baxter Supports Advancing American Kidney Health Initiative

July 10 (Reuters) - Baxter International Inc <BAX.N>::BAXTER SUPPORTS ADVANCING AMERICAN KIDNEY HEALTH INITIATIVE AND PLANS SIGNIFICANT U.S. INVESTMENT TO HELP DRIVE IMPLEMENTATION.BAXTER INTERNATIONAL INC - INVESTMENTS ARE EXPECTED TO BE MADE IN POTENTIAL NEW U.S. FACILITIES, AS WELL AS EXISTING SITES.BAXTER - TO MAKE INVESTMENTS TO SUPPORT IMPLEMENTATION OF AMERICAN KIDNEY HEALTH INITIATIVE, EXPECTED TO RESULT IN NEW U.S. MANUFACTURING CAPACITY.

Third Point Llc Reports Stake Of 4.5% In Baxter International

May 17 (Reuters) - Third Point Llc::THIRD POINT LLC REPORTS A STAKE OF 4.5% IN BAXTER INTERNATIONAL AS OF MAY 16, 2019 - SEC FILING.THIRD POINT LLC - DO NOT CURRENTLY CONTEMPLATE FURTHER SALES OF BAXTER'S SHARES FOR AT LEAST 90 DAYS.THIRD POINT LLC HAD EARLIER REPORTED A STAKE OF 5.3% IN BAXTER INTERNATIONAL AS OF DEC 3, 2018.

Baxter International Files For Offering Of €750 Million 0.400% Senior Notes Due 2024 - SEC Filing

May 14 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL INC FILES FOR OFFERING OF €750 MILLION 0.400% SENIOR NOTES DUE 2024 AND €750 MILLION 1.300% SENIOR NOTES DUE 2029 - SEC FILING.BAXTER INTERNATIONAL INC - 2024 NOTES WILL MATURE ON MAY 15, 2024 AND THE 2029 NOTES WILL MATURE ON MAY 15, 2029.BAXTER INTERNATIONAL INC - NOTES WILL BE ISSUED IN THE MINIMUM DENOMINATION OF €100,000, AND IN INTEGRAL MULTIPLES OF €1,000 IN EXCESS THEREOF..

Baxter International Announced An Increase In Quarterly Cash Dividend, To A Rate Of $0.22 Per Share Of Common Stock

May 7 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INCREASES DIVIDEND AND DECLARES QUARTERLY DIVIDEND.BAXTER INTERNATIONAL INC - ANNOUNCED AN INCREASE IN COMPANY'S QUARTERLY CASH DIVIDEND, TO A RATE OF $0.22 PER SHARE OF COMMON STOCK..BAXTER INTERNATIONAL - NEW DIVIDEND REPRESENTS ABOUT 16% INCREASE OVER PREVIOUS QUARTERLY DIVIDEND RATE OF $0.19 PER SHARE.

Baxter Reports First-Quarter 2019 Results

April 25 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL QTRLY EARNINGS PER SHARE $0.66 .BAXTER REPORTS FIRST-QUARTER 2019 RESULTS.Q1 GAAP EARNINGS PER SHARE $0.66.Q1 REVENUE $2.6 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.61 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.68 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.27 TO $3.35 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES Q2 2019 ADJUSTED EARNINGS PER SHARE $0.80 TO $0.82 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.WORLDWIDE SALES IN Q1 TOTALED APPROXIMATELY $2.6 BILLION, A DECREASE OF 2% ON A REPORTED BASIS.BAXTER IS RAISING ITS EARNINGS OUTLOOK FOR 2019..QTRLY ADJUSTED EPS OF $0.76.CONTINUES TO EXPECT SALES GROWTH OF 0 TO 1 PERCENT ON A REPORTED BASIS IN 2019.FOR Q2 COMPANY EXPECTS SALES TO DECLINE APPROXIMATELY 2 PERCENT ON A REPORTED BASIS.SEES Q2 2019 ADJUSTED EARNINGS FROM CONTINUING OPERATIONS, BEFORE SPECIAL ITEMS, OF $0.80 TO $0.82 PER DILUTED SHARE.Q2 EARNINGS PER SHARE VIEW $0.82, REVENUE VIEW $2.83 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $3.28, REVENUE VIEW $11.22 BILLION -- REFINITIV IBES DATA.

Baxter International Says CEO José Almeida's FY 2018 Compensation Was $15.6 Mln

March 26 (Reuters) - Baxter International Inc <BAX.N>::BAXTER INTERNATIONAL INC SAYS CEO JOSÉ ALMEIDA'S FY 2018 TOTAL COMPENSATION WAS $15.6 MILLION VERSUS $14.9 MILLION IN FY 2017 - SEC FILING.BAXTER INTERNATIONAL INC SAYS RATIO OF CEO ANNUAL TOTAL COMPENSATION FOR 2018 TO ANNUAL TOTAL COMPENSATION OF EMPLOYEE IS 346 TO 1.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up